SEC 13FLatest Quarter: 2026 Q3·Holdings as of 2026-09-30·~1.6 months lag (50 days)
2026 Q3 Received: 30 / 33 (3 not filed)
←Back to Directory

Farallon Capital

Manager:Thomas Steyer

● Live Quotes Active
American investment firm.
📅Filing Quarter:2026 Q3 (2026-09-30)
13F Portfolio Value (Latest Qtr)

$23.2B

Turnover

31.9%

Top 5 Concentration

44.2%

Total 13F Holdings

116

Sector Breakdown

Core Sector Coverage (4 Sectors)60.4%
Click sector to filter holdings$23.2B

📋Top 10 Holdings (of 116)

2026 Q3
Ticker / AssetSectorLive Price24h ChangeWeightSharesAction
SPDR S&P 500 ETF
ETF
17.1%
5.2M🔥 NEW
Revolution Medicines, Inc.
Healthcare
11.9%
13.4M🔴 SELL-1.3%
Warner Bros. Discovery, Inc. -
Communication Services
6.6%
49.4M🔥 NEW
Natera, Inc.
Healthcare
4.6%
2.6M🟢 BUY+18.2%
BridgeBio Pharma, Inc.
Healthcare
4.0%
14.2M🟢 BUY+33.1%
Protagonist Therapeutics, Inc.
Healthcare
3.9%
6.4M🟢 BUY+2.2%
Exelixis, Inc.
Healthcare
3.7%
14.7M🟢 BUY+8.9%
Roivant Sciences Ltd.
Healthcare
3.4%
21.7M🔥 NEW
Roku, Inc.
Communication Services
2.7%
4.2M🔥 NEW
Amazon.com Inc.
Consumer Cyclical
2.5%
2.4M🔴 SELL-8.9%

📈8-Quarter Holdings Evolution

Track historical shifts, entries, and exits of top holdings across the last 8 quarters

8 Quarters Matrix
Asset / Ticker2024 Q42025 Q12025 Q22025 Q32025 Q42026 Q12026 Q22026 Q38Q Net ChangeFull Market Search
SPY↗
SPDR S&P 500 ETF
-------17.1%+17.1%Whale Owners →
RVMD↗
Revolution Medicines, Inc.
0.8%16.0%10.1%6.7%14.0%11.6%11.7%11.9%+11.1%Whale Owners →
WBD↗
Warner Bros. Discovery, Inc. -
-------6.6%+6.6%Whale Owners →
NTRA↗
Natera, Inc.
1.9%0.8%3.7%2.5%2.0%3.1%2.8%4.6%+2.7%Whale Owners →
BBIO↗
BridgeBio Pharma, Inc.
2.1%6.9%4.6%3.2%2.6%4.0%3.7%4.0%+1.9%Whale Owners →
PTGX↗
Protagonist Therapeutics, Inc.
5.0%2.8%1.4%4.5%3.4%3.1%3.6%3.9%-1.1%Whale Owners →
EXEL↗
Exelixis, Inc.
5.6%3.4%1.9%4.8%3.6%3.1%3.4%3.7%-1.9%Whale Owners →